About Hemarus Therapeutics Limited
Data last updated:
Hemarus Therapeutics Limited is a public limited company based in Shaikpet, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74220TG2003PLC041698. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹10 Lakh. It was formerly known as Hemarus Therapeutics Private Limited and Credence Clinical Research Private Limited. It is led by directors including Kavali Dharmendra and Balaraju Jittaboina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shaikpet, Telangana.
The company has about 68 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hemarus. As per MCA filings, the company has satisfied charges of ₹75.4 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemarus.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address8 – 2 – 293/82/Jiii/359, Plot No.359 – III Raod No.80 Jubilee Hills, Shaikpet, Telangana, India – 500033
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Name History of Hemarus Therapeutics
Hemarus Therapeutics has undergone 2 name changes throughout its history. The company was previously known as Hemarus Therapeutics Private Limited, and Credence Clinical Research Private Limited. The current legal name is Hemarus Therapeutics Limited.
| Company Name | Status |
|---|---|
| Hemarus Therapeutics Limited | Current |
| Hemarus Therapeutics Private Limited | Previous |
| Credence Clinical Research Private Limited | Previous |
CIN History of Hemarus Therapeutics
Hemarus Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74220TG2003PLC041698, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74220TG2003PLC041698 | Current |
| U74220AP2003PTC041698 | Previous |
| U74220AP2003PLC041698 | Previous |
Associated Brands with Hemarus Therapeutics
Hemarus Therapeutics operates one associated brand: Hemarus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specialty plasma derived biopharmaceuticals for bleeding disorders | hemarus.co.in |
Competitors & Alternatives of Hemarus Therapeutics
Brands and companies operating in the same space as Hemarus Therapeutics Limited include GBT, Editas Medicine, Kedrion and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 GBT | Small molecules are developed for sickle cell disease treatment. | San Francisco, United States, United States | 2011 |
 Editas Medicine | Therapeutics for rare genetic diseases are developed using CRISPR technology. | Cambridge, United States, United States | 2013 |
 Kedrion | Plasma-derived therapies are developed for hemophilia and immune deficiencies. | Barga, Italy, Italy | 2001 |
 Emmaus Medical | Emmaus Medical is engaged in developing treatments for rare diseases. | Torrance, United States, United States | 2000 |
 LogicBio | Viral vectors are developed for genetic and infectious disease treatments. | Lexington, United States, United States | 2013 |
 Modus Therapeutics | Polysaccharide-based drug for Sickle Cell Disease treatment is developed. | Stockholm, Sweden, Sweden | 2011 |
 Cyclerion | Therapies for sickle cell disease and diabetic nephropathy are developed. | Cambridge, United States, United States | 2018 |
Business Activity of Hemarus Therapeutics
The main business activity of Hemarus Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Hemarus Therapeutics Limited
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Hemarus Therapeutics
Hemarus Therapeutics Limited is audited by Ganeshvenkat & Co for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ganeshvenkat & Co | Locked | Locked | Locked |
Complete auditor history for Hemarus Therapeutics Limited
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Hemarus Therapeutics Limited
Hemarus Therapeutics has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavali Dharmendra Also directs: Annapurnavijaya Bio Nutrients LLP, Lifestyle Industries LLP, Tavuk Farms LLP and 1 more | Director | 25 Oct 2024 | 1 Years 11 Months | Current |
| Balaraju Jittaboina | Director | 25 Oct 2024 | 1 Years 11 Months | Current |
| Santosh Kumar Surana | Director | 25 Oct 2024 | 1 Years 11 Months | Current |
Financials of Hemarus Therapeutics Limited FY 2025 filings available
Hemarus Therapeutics Limited reported revenue of ₹900 for FY 2025.
Ten-year financial statements for Hemarus Therapeutics Limited
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Hemarus Therapeutics
Shareholding and ownership data for Hemarus Therapeutics Limited
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hemarus Therapeutics
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2011 | Indian Overseas Bank | ₹66.68 Cr | Satisfied |
| 10 Aug 2004 | Andhra Pradesh State Financial Corporation | ₹8.72 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Hemarus Therapeutics
Hemarus Therapeutics Limited has a workforce of 68 employees as of Mar 31, 2024.
Employee and EPFO history for Hemarus Therapeutics Limited
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Hemarus Therapeutics
Hemarus Therapeutics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance for Hemarus Therapeutics Limited
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Hemarus Therapeutics
Credit ratings, litigation, and regulatory alerts for Hemarus Therapeutics Limited
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hemarus Therapeutics
MSME payment history for Hemarus Therapeutics Limited
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hemarus Therapeutics
Corporate group structure for Hemarus Therapeutics Limited
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hemarus Therapeutics
MCA filings and documents for Hemarus Therapeutics Limited
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Hemarus Therapeutics
Recent News on Hemarus Therapeutics
Frequently Asked Questions about Hemarus Therapeutics Limited
Hemarus Therapeutics is an active public limited company based in Shaikpet, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 September 2003 (23+ years old) and is registered under CIN U74220TG2003PLC041698.
Hemarus Therapeutics has 3 current directors:
- Kavali Dharmendra - Director
- Balaraju Jittaboina - Director
- Santosh Kumar Surana - Director
No. Hemarus Therapeutics has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Hemarus Therapeutics is U74220TG2003PLC041698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hemarus Therapeutics was incorporated on 16 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Hemarus Therapeutics can be reached through the website hemarus.co.in. Its registered office is in Shaikpet, Telangana, India.
The registered office of Hemarus Therapeutics is at 8 – 2 – 29382Jiii359, Plot No.359 – III Raod No.80 Jubilee Hills, Shaikpet, Telangana, India – 500033.
Hemarus Therapeutics has an authorised share capital of ₹40 Cr and a paid-up capital of ₹10 Lakh.
Hemarus Therapeutics operates in the life sciences industry, in the biotechnology segment.